VMD VIEMED HEALTHCARE, INC.

Nasdaq viemed.com


$ 6.34 $ -0.04 (-0.63 %)    

Tuesday, 11-Nov-2025 15:59:57 EST
QQQ $ 622.49 $ 0.90 (0.15 %)
DIA $ 479.63 $ 5.34 (1.13 %)
SPY $ 683.37 $ 2.90 (0.43 %)
TLT $ 89.91 $ 0.01 (0.01 %)
GLD $ 380.58 $ -0.09 (-0.02 %)
$ 6.35
$ 6.37
$ 6.15 x 25
$ 7.30 x 500
$ 6.30 - $ 6.40
$ 5.93 - $ 9.68
87,215
na
241.41M
$ 0.78
$ 17.74
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-05-2025 09-30-2025 10-Q
2 08-06-2025 06-30-2025 10-Q
3 05-07-2025 03-31-2025 10-Q
4 03-10-2025 12-31-2024 10-K
5 11-06-2024 09-30-2024 10-Q
6 08-07-2024 06-30-2024 10-Q
7 05-06-2024 03-31-2024 10-Q
8 03-06-2024 12-31-2023 10-K
9 11-01-2023 09-30-2023 10-Q
10 08-09-2023 06-30-2023 10-Q
11 05-08-2023 03-31-2023 10-Q
12 03-02-2023 12-31-2022 10-K
13 11-01-2022 09-30-2022 10-Q
14 08-02-2022 06-30-2022 10-Q
15 05-03-2022 03-31-2022 10-Q
16 03-07-2022 12-31-2021 10-K
17 11-02-2021 09-30-2021 10-Q
18 08-03-2021 06-30-2021 10-Q
19 05-03-2021 03-31-2021 10-Q
20 03-03-2021 12-31-2020 10-K
21 11-04-2020 09-30-2020 10-Q
22 08-04-2020 06-30-2020 10-Q
23 05-05-2020 03-31-2020 10-Q
24 03-04-2020 12-31-2019 10-K
25 11-05-2019 09-30-2019 10-Q
26 08-09-2019 06-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 viemed-healthcare-narrows-fy2025-sales-guidance-from-271000m-277000m-to-271000m-273000m-vs-267050m-est

Viemed Healthcare (NASDAQ:VMD) narrows FY2025 sales outlook from $271.000 million-$277.000 million to $271.000 million-$273.000...

 viemed-healthcare-q3-eps-009-inline-sales-71914m-miss-72000m-estimate

Viemed Healthcare (NASDAQ:VMD) reported quarterly earnings of $0.09 per share which met the analyst consensus estimate. This is...

Core News & Articles

Gainers Enanta Pharma (NASDAQ: ENTA) stock rose 15.6% to $9.13 during Friday's after-market session. The market value of t...

 viemed-healthcare-raises-fy2025-sales-guidance-from-256000m-265000m-to-271000m-277000m-vs-260550m-est

Viemed Healthcare (NASDAQ:VMD) raises FY2025 sales outlook from $256.000 million-$265.000 million to $271.000 million-$277.000 ...

 viemed-healthcare-q2-eps-008-inline-sales-63056m-miss-63100m-estimate

Viemed Healthcare (NASDAQ:VMD) reported quarterly earnings of $0.08 per share which met the analyst consensus estimate. This is...

 viemed-healthcare-raises-fy2025-sales-guidance-from-25400m-26500m-to-25600m-26500m-vs-26000m-est

Viemed Healthcare (NASDAQ:VMD) raises FY2025 sales outlook from $254.00 million-$265.00 million to $256.00 million-$265.00 mill...

 viemed-healthcare-q1-eps-006-inline-sales-5913m-miss-6060m-estimate

Viemed Healthcare (NASDAQ:VMD) reported quarterly earnings of $0.06 per share which met the analyst consensus estimate. This is...

 viemed-healthcare-agrees-to-acquire-lehans-medical-equipment-for-base-purchase-price-of-26m

Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), an in-home clinical care provider of post-acu...

 viemed-healthcare-expects-fy25-net-revenue-of-254m--265m-est-25150m

Adjusted EBITDA for the year ending December 31, 2025 is expected to be in the range of $54 million to $58 million.

 viemed-healthcare-q4-2024-gaap-eps-010-inline-sales-6070m-beat-5995m-estimate

Viemed Healthcare (NASDAQ:VMD) reported quarterly earnings of $0.10 per share which met the analyst consensus estimate. This is...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION